Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 60 entries
Sorted by: Best Match Show Resources per page
Combining different models of sleep regulation.

Journal of sleep research

Achermann P, Borbély AA.
PMID: 10607043
J Sleep Res. 1992 Jun;1(2):144-147. doi: 10.1111/j.1365-2869.1992.tb00028.x.

Different models have been proposed to account for processes underlying the regulation of sleep and alertness. Specific models have addressed sleep homeostasis, the nonREM-REM sleep cycle, the circadian sleep/wake rhythm, and changes of daytime alertness. We show that the...

Cite
Achermann P, Borbély AA. Combining different models of sleep regulation. J Sleep Res. 1992;1(2):144-147doi: 10.1111/j.1365-2869.1992.tb00028.x.
Achermann, P., & Borbély, A. A. (1992). Combining different models of sleep regulation. Journal of sleep research, 1(2), 144-147. https://doi.org/10.1111/j.1365-2869.1992.tb00028.x
Achermann, and Borbély. "Combining different models of sleep regulation." Journal of sleep research vol. 1,2 (1992): 144-147. doi: https://doi.org/10.1111/j.1365-2869.1992.tb00028.x
Achermann P, Borbély AA. Combining different models of sleep regulation. J Sleep Res. 1992 Jun;1(2):144-147. doi: 10.1111/j.1365-2869.1992.tb00028.x. PMID: 10607043.
Copy Download .nbib Format: NLM
[Toxicological aspects of smoking].

Schweizerische medizinische Wochenschrift

BORBELY F.
PMID: 13871193
Schweiz Med Wochenschr. 1962 Mar 10;92:283-8.

No abstract available.

Cite
BORBELY F. [Toxicological aspects of smoking]. Schweiz Med Wochenschr. 1962;92:283-8
BORBELY, F. (1962). [Toxicological aspects of smoking]. Schweizerische medizinische Wochenschrift, 92283-8.
BORBELY, F. "[Toxicological aspects of smoking]." Schweizerische medizinische Wochenschrift vol. 92 (1962): 283-8.
BORBELY F. [Toxicological aspects of smoking]. Schweiz Med Wochenschr. 1962 Mar 10;92:283-8. German. PMID: 13871193.
Copy Download .nbib Format: NLM
Gestational trophoblastic neoplasia: Novelties and challenges.

Placenta

Silva ALMD, Monteiro KDN, Sun SY, Borbely AU.
PMID: 33685753
Placenta. 2021 Dec;116:38-42. doi: 10.1016/j.placenta.2021.02.013. Epub 2021 Feb 25.

Gestational trophoblastic diseases are a group of pregnancy-related disorders, originated from trophoblast cells. They include benign and aggressive tumors, such as the invasive mole, the choriocarcinoma, the placental site trophoblastic tumor (PSTT), and the epithelioid trophoblastic tumor (ETT). These...

Cite
Silva ALMD, Monteiro KDN, Sun SY, et al. Gestational trophoblastic neoplasia: Novelties and challenges. Placenta. 2021;116:38-42doi: 10.1016/j.placenta.2021.02.013.
Silva, A. L. M. D., Monteiro, K. D. N., Sun, S. Y., & Borbely, A. U. (2021). Gestational trophoblastic neoplasia: Novelties and challenges. Placenta, 11638-42. https://doi.org/10.1016/j.placenta.2021.02.013
Silva, Ana Lucia Mendes da, et al. "Gestational trophoblastic neoplasia: Novelties and challenges." Placenta vol. 116 (2021): 38-42. doi: https://doi.org/10.1016/j.placenta.2021.02.013
Silva ALMD, Monteiro KDN, Sun SY, Borbely AU. Gestational trophoblastic neoplasia: Novelties and challenges. Placenta. 2021 Dec;116:38-42. doi: 10.1016/j.placenta.2021.02.013. Epub 2021 Feb 25. PMID: 33685753.
Copy Download .nbib Format: NLM
Sleep regulation: physiological models and hypotheses.

Acta neuropsychiatrica

Borbély AA.
PMID: 26965340
Acta Neuropsychiatr. 1995 Jun;7(2):19-20. doi: 10.1017/S0924270800037443.

The elucidation of sleep regulation is not an easy task. On one side, there is a multitude of solid yet disparate data, on the other side, the topic is tempting for engaging in wild speculation, particularly with respect to...

Cite
Borbély AA. Sleep regulation: physiological models and hypotheses. Acta Neuropsychiatr. 1995;7(2):19-20doi: 10.1017/S0924270800037443.
Borbély, A. A. (1995). Sleep regulation: physiological models and hypotheses. Acta neuropsychiatrica, 7(2), 19-20. https://doi.org/10.1017/S0924270800037443
Borbély, A A. "Sleep regulation: physiological models and hypotheses." Acta neuropsychiatrica vol. 7,2 (1995): 19-20. doi: https://doi.org/10.1017/S0924270800037443
Borbély AA. Sleep regulation: physiological models and hypotheses. Acta Neuropsychiatr. 1995 Jun;7(2):19-20. doi: 10.1017/S0924270800037443. PMID: 26965340.
Copy Download .nbib Format: NLM
Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery.

Pharmaceutics

Borbély A, Figueras E, Martins A, Esposito S, Auciello G, Monteagudo E, Di Marco A, Summa V, Cordella P, Perego R, Kemker I, Frese M, Gallinari P, Steinkühler C, Sewald N.
PMID: 30939768
Pharmaceutics. 2019 Apr 01;11(4). doi: 10.3390/pharmaceutics11040151.

Cryptophycins are potent tubulin polymerization inhibitors with picomolar antiproliferative potency in vitro and activity against multidrug-resistant (MDR) cancer cells. Because of neurotoxic side effects and limited efficacy in vivo, cryptophycin-52 failed as a clinical candidate in cancer treatment. However,...

Cite
Borbély A, Figueras E, Martins A, et al. Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery. Pharmaceutics. 2019;11(4)doi: 10.3390/pharmaceutics11040151.
Borbély, A., Figueras, E., Martins, A., Esposito, S., Auciello, G., Monteagudo, E., Di Marco, A., Summa, V., Cordella, P., Perego, R., Kemker, I., Frese, M., Gallinari, P., Steinkühler, C., & Sewald, N. (2019). Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery. Pharmaceutics, 11(4), . https://doi.org/10.3390/pharmaceutics11040151
Borbély, Adina, et al. "Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery." Pharmaceutics vol. 11,4 (2019). doi: https://doi.org/10.3390/pharmaceutics11040151
Borbély A, Figueras E, Martins A, Esposito S, Auciello G, Monteagudo E, Di Marco A, Summa V, Cordella P, Perego R, Kemker I, Frese M, Gallinari P, Steinkühler C, Sewald N. Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery. Pharmaceutics. 2019 Apr 01;11(4). doi: 10.3390/pharmaceutics11040151. PMID: 30939768; PMCID: PMC6523311.
Copy Download .nbib Format: NLM
Erratum: In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma.

ACS omega

Cazzamalli S, Figueras E, Pethő L, Borbély A, Steinkühler C, Neri D, Sewald N.
PMID: 31458304
ACS Omega. 2018 Dec 05;3(12):16743. doi: 10.1021/acsomega.8b03183. eCollection 2018 Dec 31.

[This corrects the article DOI: 10.1021/acsomega.8b02350.].

Cite
Cazzamalli S, Figueras E, Pethő L, et al. Erratum: In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega. 2018;3(12):16743doi: 10.1021/acsomega.8b03183.
Cazzamalli, S., Figueras, E., Pethő, L., Borbély, A., Steinkühler, C., Neri, D., & Sewald, N. (2018). Erratum: In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS omega, 3(12), 16743. https://doi.org/10.1021/acsomega.8b03183
Cazzamalli, Samuele, et al. "Erratum: In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma." ACS omega vol. 3,12 (2018): 16743. doi: https://doi.org/10.1021/acsomega.8b03183
Cazzamalli S, Figueras E, Pethő L, Borbély A, Steinkühler C, Neri D, Sewald N. Erratum: In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega. 2018 Dec 05;3(12):16743. doi: 10.1021/acsomega.8b03183. eCollection 2018 Dec 31. PMID: 31458304; PMCID: PMC6644080.
Copy Download .nbib Format: NLM
Period-amplitude analysis and power spectral analysis: a comparison based on all-night sleep EEG recordings.

Journal of sleep research

Geering BA, Achermann P, Eggimann F, Borbély AA.
PMID: 10607082
J Sleep Res. 1993 Sep;2(3):121-129. doi: 10.1111/j.1365-2869.1993.tb00074.x.

Both period-amplitude analysis (PAA) and power spectral analysis (PSA) were performed on all-night human sleep EEG recordings obtained from 11 subjects. The comparison of the two methods was based on the PAA variables time in band (a wave incidence...

Cite
Geering BA, Achermann P, Eggimann F, et al. Period-amplitude analysis and power spectral analysis: a comparison based on all-night sleep EEG recordings. J Sleep Res. 1993;2(3):121-129doi: 10.1111/j.1365-2869.1993.tb00074.x.
Geering, B. A., Achermann, P., Eggimann, F., & Borbély, A. A. (1993). Period-amplitude analysis and power spectral analysis: a comparison based on all-night sleep EEG recordings. Journal of sleep research, 2(3), 121-129. https://doi.org/10.1111/j.1365-2869.1993.tb00074.x
Geering, et al. "Period-amplitude analysis and power spectral analysis: a comparison based on all-night sleep EEG recordings." Journal of sleep research vol. 2,3 (1993): 121-129. doi: https://doi.org/10.1111/j.1365-2869.1993.tb00074.x
Geering BA, Achermann P, Eggimann F, Borbély AA. Period-amplitude analysis and power spectral analysis: a comparison based on all-night sleep EEG recordings. J Sleep Res. 1993 Sep;2(3):121-129. doi: 10.1111/j.1365-2869.1993.tb00074.x. PMID: 10607082.
Copy Download .nbib Format: NLM
Treatment of cystic craniopharyngiomas with yttrium-90 colloid solution.

Neurosurgical focus

Julow J, Lanyi F, Hajda M, Szeifert GT, Balint K, Drasny G, Pasztor E, Fedorcsak I, Borbely K, Nyary I.
PMID: 17206778
Neurosurg Focus. 1997 Dec 15;3(6):e6.

The authors analyzed long-term follow-up data to assess the value of intracavitary irradiation with stereotactically implanted beta-emitting radioisotope (90)Y-silicate colloid for the treatment of craniopharyngiomas. Fifty-seven craniopharyngiomas in 42 patients were selected for retrospective analysis. The yttrium-90 was implanted...

Cite
Julow J, Lanyi F, Hajda M, et al. Treatment of cystic craniopharyngiomas with yttrium-90 colloid solution. Neurosurg Focus. 1997;3(6):e6
Julow, J., Lanyi, F., Hajda, M., Szeifert, G. T., Balint, K., Drasny, G., Pasztor, E., Fedorcsak, I., Borbely, K., & Nyary, I. (1997). Treatment of cystic craniopharyngiomas with yttrium-90 colloid solution. Neurosurgical focus, 3(6), e6.
Julow, J, et al. "Treatment of cystic craniopharyngiomas with yttrium-90 colloid solution." Neurosurgical focus vol. 3,6 (1997): e6.
Julow J, Lanyi F, Hajda M, Szeifert GT, Balint K, Drasny G, Pasztor E, Fedorcsak I, Borbely K, Nyary I. Treatment of cystic craniopharyngiomas with yttrium-90 colloid solution. Neurosurg Focus. 1997 Dec 15;3(6):e6. PMID: 17206778.
Copy Download .nbib Format: NLM
Circadian rhythm of vigilance in rats: modulation by short light-dark cycles.

Neuroscience letters

Borbély AA.
PMID: 19604754
Neurosci Lett. 1975 Jul;1(1):67-71. doi: 10.1016/0304-3940(75)90014-2.

No abstract available.

Cite
Borbély AA. Circadian rhythm of vigilance in rats: modulation by short light-dark cycles. Neurosci Lett. 1975;1(1):67-71doi: 10.1016/0304-3940(75)90014-2.
Borbély, A. A. (1975). Circadian rhythm of vigilance in rats: modulation by short light-dark cycles. Neuroscience letters, 1(1), 67-71. https://doi.org/10.1016/0304-3940(75)90014-2
Borbély, A A. "Circadian rhythm of vigilance in rats: modulation by short light-dark cycles." Neuroscience letters vol. 1,1 (1975): 67-71. doi: https://doi.org/10.1016/0304-3940(75)90014-2
Borbély AA. Circadian rhythm of vigilance in rats: modulation by short light-dark cycles. Neurosci Lett. 1975 Jul;1(1):67-71. doi: 10.1016/0304-3940(75)90014-2. PMID: 19604754.
Copy Download .nbib Format: NLM
XTOP: high-resolution X-ray diffraction and imaging.

Journal of applied crystallography

Favre-Nicolin V, Baruchel J, Renevier H, Eymery J, Borbély A.
PMID: 26089754
J Appl Crystallogr. 2015 May 31;48:620. doi: 10.1107/S160057671500895X. eCollection 2015 Jun 01.

The latest virtual special issue of

Cite
Favre-Nicolin V, Baruchel J, Renevier H, et al. XTOP: high-resolution X-ray diffraction and imaging. J Appl Crystallogr. 2015;48:620doi: 10.1107/S160057671500895X.
Favre-Nicolin, V., Baruchel, J., Renevier, H., Eymery, J., & Borbély, A. (2015). XTOP: high-resolution X-ray diffraction and imaging. Journal of applied crystallography, 48620. https://doi.org/10.1107/S160057671500895X
Favre-Nicolin, Vincent, et al. "XTOP: high-resolution X-ray diffraction and imaging." Journal of applied crystallography vol. 48 (2015): 620. doi: https://doi.org/10.1107/S160057671500895X
Favre-Nicolin V, Baruchel J, Renevier H, Eymery J, Borbély A. XTOP: high-resolution X-ray diffraction and imaging. J Appl Crystallogr. 2015 May 31;48:620. doi: 10.1107/S160057671500895X. eCollection 2015 Jun 01. PMID: 26089754; PMCID: PMC4453967.
Copy Download .nbib Format: NLM
Frequency metrology in quantum degenerate helium: direct measurement of the 2 3S1 --> 2 1S0 transition.

Science (New York, N.Y.)

van Rooij R, Borbely JS, Simonet J, Hoogerland MD, Eikema KS, Rozendaal RA, Vassen W.
PMID: 21737737
Science. 2011 Jul 08;333(6039):196-8. doi: 10.1126/science.1205163.

Precision spectroscopy of simple atomic systems has refined our understanding of the fundamental laws of quantum physics. In particular, helium spectroscopy has played a crucial role in describing two-electron interactions, determining the fine-structure constant and extracting the size of...

Cite
van Rooij R, Borbely JS, Simonet J, et al. Frequency metrology in quantum degenerate helium: direct measurement of the 2 3S1 --> 2 1S0 transition. Science. 2011;333(6039):196-8doi: 10.1126/science.1205163.
van Rooij, R., Borbely, J. S., Simonet, J., Hoogerland, M. D., Eikema, K. S., Rozendaal, R. A., & Vassen, W. (2011). Frequency metrology in quantum degenerate helium: direct measurement of the 2 3S1 --> 2 1S0 transition. Science (New York, N.Y.), 333(6039), 196-8. https://doi.org/10.1126/science.1205163
van Rooij, R, et al. "Frequency metrology in quantum degenerate helium: direct measurement of the 2 3S1 --> 2 1S0 transition." Science (New York, N.Y.) vol. 333,6039 (2011): 196-8. doi: https://doi.org/10.1126/science.1205163
van Rooij R, Borbely JS, Simonet J, Hoogerland MD, Eikema KS, Rozendaal RA, Vassen W. Frequency metrology in quantum degenerate helium: direct measurement of the 2 3S1 --> 2 1S0 transition. Science. 2011 Jul 08;333(6039):196-8. doi: 10.1126/science.1205163. PMID: 21737737.
Copy Download .nbib Format: NLM
Krüppel-like factor 6 (KLF6) requires its amino terminal domain to promote villous trophoblast cell fusion.

Placenta

Miranda AL, Racca AC, Kourdova LT, Rojas ML, Cruz Del Puerto M, Rodriguez-Lombardi G, Salas AV, Travella C, da Silva ECO, de Souza ST, Fonseca EJS, Marques ALX, Borbely AU, Genti-Raimondi S, Panzetta-Dutari GM.
PMID: 34894601
Placenta. 2021 Dec 04;117:139-149. doi: 10.1016/j.placenta.2021.12.006. Epub 2021 Dec 04.

INTRODUCTION: Villous cytotrophoblast (vCTB) cells fuse to generate and maintain the syncytiotrophoblast layer required for placental development and function. Krüppel-like factor 6 (KLF6) is a ubiquitous transcription factor with an N-terminal acidic transactivation domain and a C-terminal zinc finger...

Cite
Miranda AL, Racca AC, Kourdova LT, et al. Krüppel-like factor 6 (KLF6) requires its amino terminal domain to promote villous trophoblast cell fusion. Placenta. 2021;117:139-149doi: 10.1016/j.placenta.2021.12.006.
Miranda, A. L., Racca, A. C., Kourdova, L. T., Rojas, M. L., Cruz Del Puerto, M., Rodriguez-Lombardi, G., Salas, A. V., Travella, C., da Silva, E. C. O., de Souza, S. T., Fonseca, E. J. S., Marques, A. L. X., Borbely, A. U., Genti-Raimondi, S., & Panzetta-Dutari, G. M. (2021). Krüppel-like factor 6 (KLF6) requires its amino terminal domain to promote villous trophoblast cell fusion. Placenta, 117139-149. https://doi.org/10.1016/j.placenta.2021.12.006
Miranda, Andrea L, et al. "Krüppel-like factor 6 (KLF6) requires its amino terminal domain to promote villous trophoblast cell fusion." Placenta vol. 117 (2021): 139-149. doi: https://doi.org/10.1016/j.placenta.2021.12.006
Miranda AL, Racca AC, Kourdova LT, Rojas ML, Cruz Del Puerto M, Rodriguez-Lombardi G, Salas AV, Travella C, da Silva ECO, de Souza ST, Fonseca EJS, Marques ALX, Borbely AU, Genti-Raimondi S, Panzetta-Dutari GM. Krüppel-like factor 6 (KLF6) requires its amino terminal domain to promote villous trophoblast cell fusion. Placenta. 2021 Dec 04;117:139-149. doi: 10.1016/j.placenta.2021.12.006. Epub 2021 Dec 04. PMID: 34894601.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 60 entries